» Articles » PMID: 19798052

Structural Basis of Phosphodiesterase 6 Inhibition by the C-terminal Region of the Gamma-subunit

Overview
Journal EMBO J
Date 2009 Oct 3
PMID 19798052
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The inhibitory interaction of phosphodiesterase-6 (PDE6) with its gamma-subunit (Pgamma) is pivotal in vertebrate phototransduction. Here, crystal structures of a chimaeric PDE5/PDE6 catalytic domain (PDE5/6cd) complexed with sildenafil or 3-isobutyl-1-methylxanthine and the Pgamma-inhibitory peptide Pgamma(70-87) have been determined at 2.9 and 3.0 A, respectively. These structures show the determinants and the mechanism of the PDE6 inhibition by Pgamma and suggest the conformational change of Pgamma on transducin activation. Two variable H- and M-loops of PDE5/6cd form a distinct interface that contributes to the Pgamma-binding site. This allows the Pgamma C-terminus to fit into the opening of the catalytic pocket, blocking cGMP access to the active site. Our analysis suggests that disruption of the H-M loop interface and Pgamma-binding site is a molecular cause of retinal degeneration in atrd3 mice. Comparison of the two PDE5/6cd structures shows an overlap between the sildenafil and Pgamma(70-87)-binding sites, thereby providing critical insights into the side effects of PDE5 inhibitors on vision.

Citing Articles

Structural and functional dynamics of human cone cGMP-phosphodiesterase important for photopic vision.

Singh S, Srivastava D, Boyd K, Artemyev N Proc Natl Acad Sci U S A. 2024; 122(1):e2419732121.

PMID: 39739818 PMC: 11725853. DOI: 10.1073/pnas.2419732121.


Cone photoreceptor phosphodiesterase PDE6H inhibition regulates cancer cell growth and metabolism, replicating the dark retina response.

Yalaz C, Bridges E, Alham N, Zois C, Chen J, Bensaad K Cancer Metab. 2024; 12(1):5.

PMID: 38350962 PMC: 10863171. DOI: 10.1186/s40170-023-00326-y.


Capillary leak and endothelial permeability in critically ill patients: a current overview.

Saravi B, Goebel U, Hassenzahl L, Jung C, David S, Feldheiser A Intensive Care Med Exp. 2023; 11(1):96.

PMID: 38117435 PMC: 10733291. DOI: 10.1186/s40635-023-00582-8.


Investigation of Potential cGMP-Specific PDE V and Aminopeptidase N Inhibitors of L. and Its Bioactive Components: Kinetic and Molecular Docking Studies.

Choi J, Park S, Kim S Int J Mol Sci. 2023; 24(17).

PMID: 37686129 PMC: 10488055. DOI: 10.3390/ijms241713319.


cGMP Signaling in Photoreceptor Degeneration.

Li S, Ma H, Yang F, Ding X Int J Mol Sci. 2023; 24(13).

PMID: 37446378 PMC: 10342299. DOI: 10.3390/ijms241311200.


References
1.
. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr. 1994; 50(Pt 5):760-3. DOI: 10.1107/S0907444994003112. View

2.
Artemyev N, Hamm H . Two-site high-affinity interaction between inhibitory and catalytic subunits of rod cyclic GMP phosphodiesterase. Biochem J. 1992; 283 ( Pt 1):273-9. PMC: 1131025. DOI: 10.1042/bj2830273. View

3.
Artemyev N, Natochin M, Busman M, Schey K, Hamm H . Mechanism of photoreceptor cGMP phosphodiesterase inhibition by its gamma-subunits. Proc Natl Acad Sci U S A. 1996; 93(11):5407-12. PMC: 39259. DOI: 10.1073/pnas.93.11.5407. View

4.
Murshudov G, Vagin A, Dodson E . Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr. 1997; 53(Pt 3):240-55. DOI: 10.1107/S0907444996012255. View

5.
Mou H, Cote R . The catalytic and GAF domains of the rod cGMP phosphodiesterase (PDE6) heterodimer are regulated by distinct regions of its inhibitory gamma subunit. J Biol Chem. 2001; 276(29):27527-34. DOI: 10.1074/jbc.M103316200. View